Thus, we evaluated the mRNA expression level of FGFR2 and ITGB1 in two independent databases: (i) UCSC Xena functional genomics platform (Normal Breast Benz 2020 dataset), comprising of normal breast samples from 126 healthy women with assigned breast cancer risk estimate (Gail score) [29], and (ii) TNMplot.com web platform (Breast Invasive Carcinoma dataset), enabling to compare normal and tumour paired transcriptomic data [30]. The gene discussed is FGFR2; the disease is breast carcinoma.